Self-monitoring and self-management of oral anticoagulation
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The introduction of portable monitors (point-of-care devices) for the management of patients on oral anticoagulation allows self-testing by the patient at home. Patients who self-test can either adjust their medication according to a pre-determined dose-INR schedule (self-management) or they can call a clinic to be told the appropriate dose adjustment (self-monitoring). Several trials of self-monitoring of oral anticoagulant therapy suggest this may be equal to or better than standard monitoring. OBJECTIVES: To evaluate the effects of self-monitoring or self-management of oral anticoagulant therapy compared to standard monitoring. SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2007, Issue 4), MEDLINE, EMBASE and CINAHL (to November 2007). We checked bibliographies and contacted manufacturers and authors of relevant studies. No language restrictions were applied. SELECTION CRITERIA: Outcomes analysed were thromboembolic events, mortality, major haemorrhage, minor haemorrhage, tests in therapeutic range, frequency of testing, and feasibility of self-monitoring and self-management. DATA COLLECTION AND ANALYSIS: The review authors independently extracted data. We used a fixed-effect model with the Mantzel-Haenzel method to calculate the pooled risk ratio (RR) and Peto's method to verify the results for uncommon outcomes. We examined heterogeneity amongst studies with the Chi(2) and I(2) statistics. MAIN RESULTS: We identified 18 randomized trials (4723 participants). Pooled estimates showed significant reductions in both thromboembolic events (RR 0.50, 95% CI 0.36 to 0.69) and all-cause mortality (RR 0.64, 95% CI 0.46 to 0.89). This reduction in mortality remained significant after the removal of low-quality studies (RR 0.65, 95% CI 0.46 to 0.90). Trials of self-management alone showed significant reductions in thromboembolic events (RR 0.47, 95% CI 0.31 to 0.70) and all-cause mortality (RR 0.55, 95% CI 0.36 to 0.84); self-monitoring did not (thrombotic events RR 0.57, 95% CI 0.32 to 1.00; mortality RR 0.84, 95% CI 0.50 to 1.41). Self-monitoring significantly reduced major haemorrhages (RR 0.56, 95% CI 0.35 to 0.91) whilst self-management did not (RR 1.12, 95% CI 0.78 to 1.61). Twelve trials reported improvements in the percentage of mean INR measurements in the therapeutic range. No heterogeneity was identified in any of these comparisons. AUTHORS' CONCLUSIONS: Compared to standard monitoring, patients who self-monitor or self-manage can improve the quality of their oral anticoagulation therapy. The number of thromboembolic events and mortality were decreased without increases in harms. However, self-monitoring or self-management were not feasible for up to half of the patients requiring anticoagulant therapy. Reasons included patient refusal, exclusion by their general practitioner, and inability to complete training.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Self-citationKearon, C., Ginsberg, J. S., Kovacs, M. J., Anderson, D. R., Wells, P., Julian, J. A., MacKinnon, B., Weitz, J. I., Crowther, M. A., Dolan, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035422 · Cited by 751
Pogue, J. M., & Yusuf, S. (1997) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00051-2 · Cited by 415
Devereaux, P. J., Choi, P. T.-L., El-Dika, S., Bhandari, M., Montori, V. M., Schünemann, H. J., Garg, A. X., Busse, J. W., Heels-Ansdell, D., Ghali, W. A., et al. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.03.017 · Cited by 209
Research works printed but not linked: 87
- Beyth, 2000, A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial, Annals of Internal Medicine, 133, 687, 10.7326/0003-4819-133-9-200011070-00010 · DOI · Paper page
- Christensen, 2006, Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial, European Journal of Internal Medicine, 17, 260, 10.1016/j.ejim.2005.11.021 · DOI
- Cromheecke, 2000, Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison, Lancet, 356, 97, 10.1016/S0140-6736(00)02470-3 · DOI · Paper page
- Fitzmaurice, 2002, A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management, Journal of Clinical Pathology, 55, 845, 10.1136/jcp.55.11.845 · doi:10.1136/jcp.55.11.845
- Fitzmaurice, 2005, Self management of oral anticoagulation: randomised trial, BMJ, 331, 1057, 10.1136/bmj.38618.580903.AE · DOI
- McCahon, 2003, SMART: self-management of anticoagulation, a randomised trial, BMC Family Practice, 4, 11, 10.1186/1471-2296-4-11 · DOI
- Murray, 2004, Training for patients in a randomised controlled trial of self management of warfarin treatment, BMJ, 328, 437, 10.1136/bmj.328.7437.437 · DOI
- Gadisseur, 2003, Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial, Archives of Internal Medicine, 163, 2639, 10.1001/archinte.163.21.2639 · DOI
- Gadisseur, 2004, Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life, Journal of Thrombosis and Haemostasis, 2, 584, 10.1111/j.1538-7836.2004.00659.x · DOI
- Gadisseur, 2003, Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial, Archives of Internal Medicine, 163, 2639, 10.1001/archinte.163.21.2639 · DOI
- Gadisseur, 2004, Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life, Journal of Thrombosis and Haemostasis, 2, 584, 10.1111/j.1538-7836.2004.00659.x · DOI
- Gardiner, 2005, Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring, British Journal of Haematology, 128, 242, 10.1111/j.1365-2141.2004.05300.x · DOI
- Horstkotte, 1998, Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease, Journal of Thrombosis and Thrombolysis, 5 Suppl 1, 19, 10.1023/A:1013228718768 · doi:10.1023/a:1013228718768
- Kaatz, 2001, Anticoagulation therapy home andoffice monitoring evaluation study, Journal of Thrombosis and Thrombolysis, 12, 111
- Khan, 2004, The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation, British Journal of Haematology, 126, 557, 10.1111/j.1365-2141.2004.05074.x · DOI · Paper page
- Koertke, 2000, INR self-management following mechanical heart valve replacement, Journal of Thrombosis and Thrombolysis, 9 Suppl 1, 41, 10.1023/A:1018712520472 · doi:10.1023/a:1018712520472
- Koertke, 2003, INR self-management permits lower anticoagulation levels after mechanical heart valve replacement, Circulation, 108, II
- Körtke, 2001, International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?, Annals of Thoracic Surgery, 72, 44, 10.1016/S0003-4975(01)02656-X · doi:10.1016/s0003-4975(01)02656-x
- Körtke, 2001, INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial), Zeitschrift fur Kardiologie, 90 Suppl, 6118
- Menéndez-Jándula, 2005, Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial, Annals of Internal Medicine, 142, 1, 10.7326/0003-4819-142-1-200501040-00006 · DOI · Paper page
- Sawicki, 1999, A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation, JAMA, 281, 145, 10.1001/jama.281.2.145 · DOI · Paper page
- Sawicki, 2003, Long-term results of patients' self-management of oral anticoagulation, Journal of Clinical & Basic Cardiology, 6, 59
- Sidhu, 2001, Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients, Annals of Thoracic Surgery, 72, 1523, 10.1016/S0003-4975(01)03049-1 · doi:10.1016/s0003-4975(01)03049-1
- Siebenhofer, 2007, Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial, Thrombosis and Haemostasis, 97, 408, 10.1160/TH06-08-0482 · DOI
- Sunderji, 1999, Outpatient self-management of warfarin therapy: A pilot study, Pharmacotherapy, 19, 787, 10.1592/phco.19.9.787.31546 · doi:10.1592/phco.19.9.787.31546
- Sunderji, 2004, A randomized trial of patient self-managed versus physician-managed oral anticoagulation, Canadian Journal of Cardiology, 20, 1117
- Völler, 2005, Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study), Zeitschrift fur Kardiologie, 94, 182, 10.1007/s00392-005-0199-0 · DOI
- White, 1989, Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study, Annals of Internal Medicine, 111, 730, 10.7326/0003-4819-111-9-730 · doi:10.7326/0003-4819-111-9-730
- Christensen, 2001, Self-management of oral anticoagulant therapy for mechanical heart valve patients, Scandinavian. Cardiovascular Journal, 35, 107, 10.1080/140174301750164772 · doi:10.1080/140174301750164772
- Christensen, 2003, Mechanical heart valve patients can manage oral anticoagulant therapy themselves, European Journal of Cardio-Thoracic Surgery, 23, 292, 10.1016/s1010-7940(02)00817-5 · doi:10.1016/s1010-7940(02)00817-5
- Hambleton, 2003, Home monitoring of anticoagulation, Journal of Thrombosis and Thrombolysis, 16, 39, 10.1023/B:THRO.0000014591.32012.1f · doi:10.1023/b:thro.0000014591.32012.1f
- Hasenkam, 1997, Practicability of patient self-testing of oral anticoagulant therapy by the international normalized ratio (INR) using a portable whole blood monitor. A pilot investigation, Thrombosis Research, 85, 77, 10.1016/S0049-3848(96)00224-1 · doi:10.1016/s0049-3848(96)00224-1
- Hasenkam, 1998, Self management of peroral anticoagulant therapy in patients with artificial heart valves, Ugeskrift for Laeger, 160, 6811
- Heidinger, 2000, Clinical outcome of self-management of oral anticoagulation in patients with atrial fibrillation or deep vein thrombosis, Thrombosis Research, 98, 287, 10.1016/S0049-3848(00)00181-X · doi:10.1016/s0049-3848(00)00181-x
- Horstkotte, 2004, Improvement of oral anticoagulation therapy by INR self-management, Journal of Heart Valve Disease, 13, 335
- Lafata, 2000, Anticoagulation clinics and patient self-testing for patients on chronic warfarin therapy: A cost-effectiveness analysis, Journal of Thrombosis and Thrombolysis, 9 Suppl 1, 13, 10.1023/A:1018704318655 · DOI
- Leger, 2004, Therapeutic education of patients receiving anticoagulants for thromboembolic venous disease: Description of the Educ'AVK program, Journal des Maladies Vasculaires, 29, 145, 10.1016/S0398-0499(04)96736-4 · doi:10.1016/s0398-0499(04)96736-4
- Levi, 2001, Self-monitoring and self dosing of oral anticoagulant therapy with vitamin K antagonists, Tijdschrift voor Geneeskunde, 145, 2313
- Piso, 2002, The quality of oral anticoagulation before, during and after a period of patient self-management, Thrombosis Research, 106, 101, 10.1016/S0049-3848(02)00098-1 · doi:10.1016/s0049-3848(02)00098-1
- Rosengart, 2002, Anticoagulation self-testing after heart valve replacement, Journal of Heart Valve Disease, 11 Suppl, 61
- Schmidtke, 2001, Quality of life after aortic valve replacement - Anticoagulation self-management or conventional therapy in mechanical prostheses versus pulmonary autograft, Zeitschrift fur Kardiologie, 90, 860, 10.1007/s003920170084 · doi:10.1007/s003920170084
- Sunderji, 2005, Clinical impact of point-of-care vs laboratory measurement of anticoagulation, American Journal of Clinical Pathology, 123, 184, 10.1309/P2Y3VM4AXPVUDAW3 · doi:10.1309/p2y3vm4axpvudaw3
- Watzke, 2000, A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation, Thrombosis and Haemostasis, 84, 931
- Matchar, 2005, The impact of patient self-testing of prothrombin time for managing anticoagulation: rationale and design of VA Cooperative Study #481--the Home INR Study (THINRS) [Protocol], Journal of Thrombosis and Thrombolysis, 19, 163, 10.1007/s11239-005-1452-0 · DOI
- Anderson, 1993, Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy, Archives of Internal Medicine, 153, 1441, 10.1001/archinte.1993.00410120027004 · doi:10.1001/archinte.1993.00410120027004
- Ansell, 1996, Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management, American Heart Journal, 132, 1095, 10.1016/S0002-8703(96)90040-X · DOI
- Ansell, 2001, Managing oral anticoagulant therapy, Chest, 119 Suppl, 22, 10.1378/chest.119.1_suppl.22S · DOI · Paper page
- Ansell, 2004, The pharmacology and management of the vitamin K antagonist, Chest, 126, 204, 10.1378/chest.126.3_suppl.204S · DOI · Paper page
- Ansell, 2005, Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation, International Journal of Cardiology, 99, 37, 10.1016/j.ijcard.2003.11.008 · DOI
- Baglin, 1994, Decentralization of anticoagulant control, Clinical and Laboratory Haematology, 16, 327
- Bazian, Self-management of oral anticoagulation, Evidence-Based Healthcare and Public Health, 9, 334
- Breckenridge, 1978, Oral anticoagulant drugs: pharmacokinetic aspects, Seminars in Hematology, 15, 19
- Brown A Wells P Jaffey J McGahan L Poon M-C Cimon K Point-of-care monitoring devices for long-term oral anticoagulation therapy: clinical and cost effectiveness Canadian Agency for Drugs and Technologies in Health 2007 · DOI
- Buckingham, 2002, Anticoagulants for atrial fibrillation: why is the treatment rate so low?, Clinical Cardiology, 25, 447, 10.1002/clc.4960251003 · DOI
- Cannegieter, 1995, Optimal oral anticoagulant therapy in patients with mechanical heart valves, New England Journal of Medicine, 333, 11, 10.1056/NEJM199507063330103 · DOI · Paper page
- Caro, 2004, An economic model of stroke in atrial fibrillation: the cost of suboptimal oral anticoagulation, The American Journal of Managed Care, 10, 451
- Christensen, 2007, Self-management of oral anticoagulant therapy: a systematic review and meta-analysis, International Journal of Cardiology, 118, 54, 10.1016/j.ijcard.2006.06.018 · DOI
- Christensen, 2009, International normalised ratio (INR) measured on the CoaguChek S and XS compared with the laboratory for determination of precision and accuracy, Thrombosis and Haemostasis, 101, 563, 10.1160/TH08-09-0601 · DOI
- Connolly, 1991, Canadian Atrial Fibrillation Anticoagulation (CAFA) Study, Journal of the American College of Cardiology, 18, 349, 10.1016/0735-1097(91)90585-W · DOI · Paper page
- Corporative, 1990, The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators, New England Journal of Medicine, 323, 1505, 10.1056/NEJM199011293232201 · DOI · Paper page
- Solà-Morales Serra, 2005, Portable coagulometers: a systematic review of the evidence on self-management of oral anticoagulant treatment, Medicina Clinica (Barc), 124, 321
- DerSimonian, 1986, Meta-analysis in clinical trials, Controlled Clinical Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
- Devereaux, 2001, Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study, BMJ, 323, 1, 10.1136/bmj.323.7323.1218 · DOI · Paper page
- Dickersin, 1994, Identifying relevant studies for systematic reviews, BMJ, 309, 1286, 10.1136/bmj.309.6964.1286 · DOI · Paper page
- 1993, Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group, Lancet, 342, 1255, 10.1016/0140-6736(93)92358-Z · DOI · Paper page
- Ezekowitz, 1992, Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators, New England Journal of Medicine, 327, 1406, 10.1056/NEJM199211123272002 · DOI · Paper page
- Fitzmaurice, 2001, Recommendations for patients undertaking self management of oral anticoagulation, BMJ, 323, 985, 10.1136/bmj.323.7319.985 · DOI
- Gadisseur, 2004, Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life, Journal of Thrombosis and Haemostasis, 2, 584, 10.1111/j.1538-7836.2004.00659.x · DOI
- Go, 2003, Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?, JAMA, 290, 2685, 10.1001/jama.290.20.2685 · DOI · Paper page
- Greenblatt, 2005, Interaction of warfarin with drugs, natural substances, and foods, Journal of Clinical Pharmacology, 45, 127, 10.1177/0091270004271404 · DOI · Paper page
- Heneghan, 2006, Self-monitoring of oral anticoagulation: a systematic review and meta-analysis, Lancet, 367, 404, 10.1016/S0140-6736(06)68139-7 · DOI · Paper page
- Heneghan, 2008, Oral Anticoagulation Therapy, 229, 10.1002/9780470696323.ch17 · DOI
- Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
- Hirsh, 1998, Oral anticoagulation mechanism of action, clinical effectiveness, and optimal therapeutic range, Chest, 114 Suppl, 445, 10.1378/chest.114.5_Supplement.445S · DOI · Paper page
- Hirsh, 2001, Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range, Chest, 119 Suppl 1, 8, 10.1378/chest.119.1_suppl.8S · DOI · Paper page
- Hylek, 1996, An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation, New England Journal of Medicine, 335, 540, 10.1056/NEJM199608223350802 · DOI · Paper page
- Manotti, 2001, Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated Program for Oral Anticoagulant Treatment), Haematologica, 86, 1060
- Montori, 2005, Randomized trials stopped early for benefit: a systematic review, JAMA, 294, 2203, 10.1001/jama.294.17.2203 · DOI · Paper page
- Poller, 2006, Quality assessment of CoaguChek point-of-care prothrombin time monitors: comparison of the European community-approved procedure and conventional external quality assessment, Clinical Chemistry, 52, 1843, 10.1373/clinchem.2006.071639 · doi:10.1373/clinchem.2006.071639
- Regier, 2006, Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy, CMAJ, 174, 1847, 10.1503/cmaj.051104 · DOI
- Sawicki, 2003, Self-management of oral anticoagulation: long-term results, Journal of Internal Medicine, 254, 515, 10.1046/j.1365-2796.2003.01215.x · doi:10.1046/j.1365-2796.2003.01215.x
- Siebenhofer, 2004, Systematic review of studies of self-management of oral anticoagulation, Thrombosis and Haemostasis, 91, 225, 10.1160/TH03-09-0598 · DOI
- 1996, Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial, Lancet, 348, 633, 10.1016/S0140-6736(96)03487-3 · DOI · Paper page
- Stafford, 1998, Recent national patterns of warfarin use in atrial fibrillation, Circulation, 97, 1231, 10.1161/01.CIR.97.13.1231 · DOI · Paper page
- Taborski, 1999, Cost-effectiveness of self-managed anticoagulant therapy in Germany, Seminars in Thrombosis and Hemostasis, 25, 103, 10.1055/s-2007-996432 · doi:10.1055/s-2007-996432
- Ødegaard, 2004, Self-management in anticoagulation--a meta-analysis, Tidsskrift for den Norske Laegeforening, 124, 2900
- Heneghan, 2006, Self-monitoring of oral anticoagulation: a systematic review and meta-analysis, Lancet, 367, 404, 10.1016/S0140-6736(06)68139-7 · DOI · Paper page
Cited by
Pulmonary embolism and deep vein thrombosis
Goldhaber, S. Z., & Bounameaux, H. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61904-1 · Cited by 1,054
Self-Management: A Comprehensive Approach to Management of Chronic Conditions
Grady, P. A., & Gough, L. L. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.302041 · Cited by 923
Dineen-Griffin, S., Garcia-Cardenas, V., Williams, K., & Benrimoj, S. I. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220116 · Cited by 639
Heneghan, C., Ward, A., Perera, R., Bankhead, C., Fuller, A., Stevens, R., Bradford, K., Tyndel, S., Alonso-Coello, P., Ansell, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61294-4 · Cited by 372
Self-citationRyan, R. E., Santesso, N., Lowe, D., Hill, S., Grimshaw, J. M., Prictor, M., Kaufman, C., Cowie, G., & Taylor, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007768.pub3 · Cited by 273
Metadata
- Authors
- Garcia-Alamino, J. M., Ward, A. M., Alonso-Coello, P., Perera, R., Bankhead, C., Fitzmaurice, D., & Heneghan, C. J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2010-04-14
- Issue
- 4
- Pages
- CD003839-CD003839
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4231613903
- Cited by
- 109
- References
- 4
- Type
- reference entry
- Language
- en
- Update notices
- new_version (2016-07-05)
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Self-monitoring and self-management of oral anticoagulation. https://app.cochat.ai/papers/10.1002/14651858.cd003839.pub2
- The paper
- Garcia-Alamino, J. M., Ward, A. M., Alonso-Coello, P., Perera, R., Bankhead, C., Fitzmaurice, D., & Heneghan, C. J. (2010). Self-monitoring and self-management of oral anticoagulation. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd003839.pub2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.